1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Long-Acting Injectables Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Small and Middle Sized Molecule 1.2.3 Large Sized Molecule 1.3 Market by Application 1.3.1 Global Long-Acting Injectables Market Share by Application: 2020 VS 2026 1.3.2 Schizophrenia 1.3.3 Other Psychotic Disorders 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Long-Acting Injectables Market Perspective (2015-2026) 2.2 Global Long-Acting Injectables Growth Trends by Regions 2.2.1 Long-Acting Injectables Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Long-Acting Injectables Historic Market Share by Regions (2015-2020) 2.2.3 Long-Acting Injectables Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Long-Acting Injectables Players by Market Size 3.1.1 Global Top Long-Acting Injectables Players by Revenue (2015-2020) 3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2015-2020) 3.2 Global Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Long-Acting Injectables Revenue 3.4 Global Long-Acting Injectables Market Concentration Ratio 3.4.1 Global Long-Acting Injectables Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectables Revenue in 2019 3.5 Key Players Long-Acting Injectables Area Served 3.6 Key Players Long-Acting Injectables Product Solution and Service 3.7 Date of Enter into Long-Acting Injectables Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Long-Acting Injectables Breakdown Data by Type (2015-2026) 4.1 Global Long-Acting Injectables Historic Market Size by Type (2015-2020) 4.2 Global Long-Acting Injectables Forecasted Market Size by Type (2021-2026) 5 Long-Acting Injectables Breakdown Data by Application (2015-2026) 5.1 Global Long-Acting Injectables Historic Market Size by Application (2015-2020) 5.2 Global Long-Acting Injectables Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Long-Acting Injectables Market Size (2015-2026) 6.2 North America Long-Acting Injectables Market Size by Type (2015-2020) 6.3 North America Long-Acting Injectables Market Size by Application (2015-2020) 6.4 North America Long-Acting Injectables Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Long-Acting Injectables Market Size (2015-2026) 7.2 Europe Long-Acting Injectables Market Size by Type (2015-2020) 7.3 Europe Long-Acting Injectables Market Size by Application (2015-2020) 7.4 Europe Long-Acting Injectables Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Long-Acting Injectables Market Size (2015-2026) 8.2 China Long-Acting Injectables Market Size by Type (2015-2020) 8.3 China Long-Acting Injectables Market Size by Application (2015-2020) 8.4 China Long-Acting Injectables Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Long-Acting Injectables Market Size (2015-2026) 9.2 Japan Long-Acting Injectables Market Size by Type (2015-2020) 9.3 Japan Long-Acting Injectables Market Size by Application (2015-2020) 9.4 Japan Long-Acting Injectables Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Long-Acting Injectables Market Size (2015-2026) 10.2 Southeast Asia Long-Acting Injectables Market Size by Type (2015-2020) 10.3 Southeast Asia Long-Acting Injectables Market Size by Application (2015-2020) 10.4 Southeast Asia Long-Acting Injectables Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Eli Lilly 11.1.1 Eli Lilly Company Details 11.1.2 Eli Lilly Business Overview 11.1.3 Eli Lilly Long-Acting Injectables Introduction 11.1.4 Eli Lilly Revenue in Long-Acting Injectables Business (2015-2020)) 11.1.5 Eli Lilly Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Long-Acting Injectables Introduction 11.2.4 Pfizer Revenue in Long-Acting Injectables Business (2015-2020) 11.2.5 Pfizer Recent Development 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Company Details 11.3.2 GlaxoSmithKline Business Overview 11.3.3 GlaxoSmithKline Long-Acting Injectables Introduction 11.3.4 GlaxoSmithKline Revenue in Long-Acting Injectables Business (2015-2020) 11.3.5 GlaxoSmithKline Recent Development 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Details 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Long-Acting Injectables Introduction 11.4.4 Johnson & Johnson Revenue in Long-Acting Injectables Business (2015-2020) 11.4.5 Johnson & Johnson Recent Development 11.5 Lupin Limited 11.5.1 Lupin Limited Company Details 11.5.2 Lupin Limited Business Overview 11.5.3 Lupin Limited Long-Acting Injectables Introduction 11.5.4 Lupin Limited Revenue in Long-Acting Injectables Business (2015-2020) 11.5.5 Lupin Limited Recent Development 11.6 Zogenix 11.6.1 Zogenix Company Details 11.6.2 Zogenix Business Overview 11.6.3 Zogenix Long-Acting Injectables Introduction 11.6.4 Zogenix Revenue in Long-Acting Injectables Business (2015-2020) 11.6.5 Zogenix Recent Development 11.7 DURECT 11.7.1 DURECT Company Details 11.7.2 DURECT Business Overview 11.7.3 DURECT Long-Acting Injectables Introduction 11.7.4 DURECT Revenue in Long-Acting Injectables Business (2015-2020) 11.7.5 DURECT Recent Development 11.8 Medincel 11.8.1 Medincel Company Details 11.8.2 Medincel Business Overview 11.8.3 Medincel Long-Acting Injectables Introduction 11.8.4 Medincel Revenue in Long-Acting Injectables Business (2015-2020) 11.8.5 Medincel Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Long-Acting Injectables Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Small and Middle Sized Molecule Table 4. Key Players of Large Sized Molecule Table 5. Global Long-Acting Injectables Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 6. Global Long-Acting Injectables Market Size by Regions (US$ Million): 2020 VS 2026 Table 7. Global Long-Acting Injectables Market Size by Regions (2015-2020) (US$ Million) Table 8. Global Long-Acting Injectables Market Share by Regions (2015-2020) Table 9. Global Long-Acting Injectables Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 10. Global Long-Acting Injectables Market Share by Regions (2021-2026) Table 11. Long-Acting Injectables Market Market Trends Table 12. Long-Acting Injectables Market Drivers Table 13. Long-Acting Injectables Market Challenges Table 14. Long-Acting Injectables Market Restraints Table 15. Global Long-Acting Injectables Revenue by Players (2015-2020) (US$ Million) Table 16. Global Long-Acting Injectables Market Share by Players (2015-2020) Table 17. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-Acting Injectables as of 2019) Table 18. Global Long-Acting Injectables by Players Market Concentration Ratio (CR5 and HHI) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Long-Acting Injectables Product Solution and Service Table 21. Mergers & Acquisitions, Expansion Plans Table 22. Global Long-Acting Injectables Market Size by Type (2015-2020) (US$ Million) Table 23. Global Long-Acting Injectables Market Size Share by Type (2015-2020) Table 24. Global Long-Acting Injectables Revenue Market Share by Type (2021-2026) Table 25. Global Long-Acting Injectables Market Size Share by Application (2015-2020) Table 26. Global Long-Acting Injectables Market Size by Application (2015-2020) (US$ Million) Table 27. Global Long-Acting Injectables Market Size Share by Application (2021-2026) Table 28. North America Long-Acting Injectables Market Size by Type (2015-2020) (US$ Million) Table 29. North America Long-Acting Injectables Market Share by Type (2015-2020) Table 30. North America Long-Acting Injectables Market Size by Application (2015-2020) (US$ Million) Table 31. North America Long-Acting Injectables Market Share by Application (2015-2020) Table 32. North America Long-Acting Injectables Market Size by Country (US$ Million) (2015-2020) Table 33. North America Long-Acting Injectables Market Share by Country (2015-2020) Table 34. Europe Long-Acting Injectables Market Size by Type (2015-2020) (US$ Million) Table 35. Europe Long-Acting Injectables Market Share by Type (2015-2020) Table 36. Europe Long-Acting Injectables Market Size by Application (2015-2020) (US$ Million) Table 37. Europe Long-Acting Injectables Market Share by Application (2015-2020) Table 38. Europe Long-Acting Injectables Market Size by Country (US$ Million) (2015-2020) Table 39. Europe Long-Acting Injectables Market Share by Country (2015-2020) Table 40. China Long-Acting Injectables Market Size by Type (2015-2020) (US$ Million) Table 41. China Long-Acting Injectables Market Share by Type (2015-2020) Table 42. China Long-Acting Injectables Market Size by Application (2015-2020) (US$ Million) Table 43. China Long-Acting Injectables Market Share by Application (2015-2020) Table 44. China Long-Acting Injectables Market Size by Region (US$ Million) (2015-2020) Table 45. China Long-Acting Injectables Market Share by Region (2015-2020) Table 46. Japan Long-Acting Injectables Market Size by Type (2015-2020) (US$ Million) Table 47. Japan Long-Acting Injectables Market Share by Type (2015-2020) Table 48. Japan Long-Acting Injectables Market Size by Application (2015-2020) (US$ Million) Table 49. Japan Long-Acting Injectables Market Share by Application (2015-2020) Table 50. Japan Long-Acting Injectables Market Size by Country (US$ Million) (2015-2020) Table 51. Japan Long-Acting Injectables Market Share by Country (2015-2020) Table 52. Southeast Asia Long-Acting Injectables Market Size by Type (2015-2020) (US$ Million) Table 53. Southeast Asia Long-Acting Injectables Market Share by Type (2015-2020) Table 54. Southeast Asia Long-Acting Injectables Market Size by Application (2015-2020) (US$ Million) Table 55. Southeast Asia Long-Acting Injectables Market Share by Application (2015-2020) Table 56. Southeast Asia Long-Acting Injectables Market Size by Country (US$ Million) (2015-2020) Table 57. Southeast Asia Long-Acting Injectables Market Share by Country (2015-2020) Table 58. Eli Lilly Company Details Table 59. Eli Lilly Business Overview Table 60. Eli Lilly Product Table 61. Eli Lilly Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million) Table 62. Eli Lilly Recent Development Table 63. Pfizer Company Details Table 64. Pfizer Business Overview Table 65. Pfizer Product Table 66. Pfizer Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million) Table 67. Pfizer Recent Development Table 68. GlaxoSmithKline Company Details Table 69. GlaxoSmithKline Business Overview Table 70. GlaxoSmithKline Product Table 71. GlaxoSmithKline Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million) Table 72. GlaxoSmithKline Recent Development Table 73. Johnson & Johnson Company Details Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson Product Table 76. Johnson & Johnson Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million) Table 77. Johnson & Johnson Recent Development Table 78. Lupin Limited Company Details Table 79. Lupin Limited Business Overview Table 80. Lupin Limited Product Table 81. Lupin Limited Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million) Table 82. Lupin Limited Recent Development Table 83. Zogenix Company Details Table 84. Zogenix Business Overview Table 85. Zogenix Product Table 86. Zogenix Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million) Table 87. Zogenix Recent Development Table 88. DURECT Company Details Table 89. DURECT Business Overview Table 90. DURECT Product Table 91. DURECT Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million) Table 92. DURECT Recent Development Table 93. Medincel Business Overview Table 94. Medincel Product Table 95. Medincel Company Details Table 96. Medincel Revenue in Long-Acting Injectables Business (2015-2020) (US$ Million) Table 97. Medincel Recent Development Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Global Long-Acting Injectables Market Share by Type: 2020 VS 2026 Figure 2. Small and Middle Sized Molecule Features Figure 3. Large Sized Molecule Features Figure 4. Global Long-Acting Injectables Market Share by Application: 2020 VS 2026 Figure 5. Schizophrenia Case Studies Figure 6. Other Psychotic Disorders Case Studies Figure 7. Long-Acting Injectables Report Years Considered Figure 8. Global Long-Acting Injectables Market Size (US$ Million), YoY Growth 2015-2026 Figure 9. Global Long-Acting Injectables Market Share by Regions: 2020 VS 2026 Figure 10. Global Long-Acting Injectables Market Share by Regions (2021-2026) Figure 11. Global Long-Acting Injectables Market Share by Players in 2019 Figure 12. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-Acting Injectables as of 2019 Figure 13. The Top 10 and 5 Players Market Share by Long-Acting Injectables Revenue in 2019 Figure 14. North America Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 15. United States Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 16. Canada Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 17. Europe Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 18. Germany Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. France Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. U.K. Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Italy Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Russia Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Nordic Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Rest of Europe Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Asia-Pacific Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. China Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Japan Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. South Korea Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Southeast Asia Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. India Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Australia Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Rest of Asia-Pacific Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Latin America Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Mexico Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Brazil Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Middle East & Africa Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Turkey Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Saudi Arabia Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. UAE Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Rest of Middle East & Africa Long-Acting Injectables Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Eli Lilly Revenue Growth Rate in Long-Acting Injectables Business (2015-2020) Figure 42. Pfizer Revenue Growth Rate in Long-Acting Injectables Business (2015-2020) Figure 43. GlaxoSmithKline Revenue Growth Rate in Long-Acting Injectables Business (2015-2020) Figure 44. Johnson & Johnson Revenue Growth Rate in Long-Acting Injectables Business (2015-2020) Figure 45. Lupin Limited Revenue Growth Rate in Long-Acting Injectables Business (2015-2020) Figure 46. Zogenix Revenue Growth Rate in Long-Acting Injectables Business (2015-2020) Figure 47. DURECT Revenue Growth Rate in Long-Acting Injectables Business (2015-2020) Figure 48. Medincel Revenue Growth Rate in Long-Acting Injectables Business (2015-2020) Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation Figure 51. Key Executives Interviewed

Eli Lilly Pfizer GlaxoSmithKline Johnson & Johnson Lupin Limited Zogenix DURECT Medincel